Hecht, M., Gostian, A. O., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., . . . Fietkau, R. (2020). Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: First results of CheckRad-CD8. J Immunother Cancer.
Chicago ZitierstilHecht, Markus, et al. "Safety and Efficacy of Single Cycle Induction Treatment With Cisplatin/docetaxel/ Durvalumab/tremelimumab in Locally Advanced HNSCC: First Results of CheckRad-CD8." J Immunother Cancer 2020.
MLA ZitierstilHecht, Markus, et al. "Safety and Efficacy of Single Cycle Induction Treatment With Cisplatin/docetaxel/ Durvalumab/tremelimumab in Locally Advanced HNSCC: First Results of CheckRad-CD8." J Immunother Cancer 2020.